Cargando…
FLT3-IRAK dual targeting: an exciting new therapeutic option guided by adaptive activation of immune response pathways
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210206/ https://www.ncbi.nlm.nih.gov/pubmed/32395555 http://dx.doi.org/10.21037/atm.2020.01.21 |
| _version_ | 1783531235244507136 |
|---|---|
| author | Rabik, Cara A. Wang, Jiawan Pratilas, Christine A. |
| author_facet | Rabik, Cara A. Wang, Jiawan Pratilas, Christine A. |
| author_sort | Rabik, Cara A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7210206 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72102062020-05-11 FLT3-IRAK dual targeting: an exciting new therapeutic option guided by adaptive activation of immune response pathways Rabik, Cara A. Wang, Jiawan Pratilas, Christine A. Ann Transl Med Editorial Commentary AME Publishing Company 2020-04 /pmc/articles/PMC7210206/ /pubmed/32395555 http://dx.doi.org/10.21037/atm.2020.01.21 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Rabik, Cara A. Wang, Jiawan Pratilas, Christine A. FLT3-IRAK dual targeting: an exciting new therapeutic option guided by adaptive activation of immune response pathways |
| title | FLT3-IRAK dual targeting: an exciting new therapeutic option guided by adaptive activation of immune response pathways |
| title_full | FLT3-IRAK dual targeting: an exciting new therapeutic option guided by adaptive activation of immune response pathways |
| title_fullStr | FLT3-IRAK dual targeting: an exciting new therapeutic option guided by adaptive activation of immune response pathways |
| title_full_unstemmed | FLT3-IRAK dual targeting: an exciting new therapeutic option guided by adaptive activation of immune response pathways |
| title_short | FLT3-IRAK dual targeting: an exciting new therapeutic option guided by adaptive activation of immune response pathways |
| title_sort | flt3-irak dual targeting: an exciting new therapeutic option guided by adaptive activation of immune response pathways |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210206/ https://www.ncbi.nlm.nih.gov/pubmed/32395555 http://dx.doi.org/10.21037/atm.2020.01.21 |
| work_keys_str_mv | AT rabikcaraa flt3irakdualtargetinganexcitingnewtherapeuticoptionguidedbyadaptiveactivationofimmuneresponsepathways AT wangjiawan flt3irakdualtargetinganexcitingnewtherapeuticoptionguidedbyadaptiveactivationofimmuneresponsepathways AT pratilaschristinea flt3irakdualtargetinganexcitingnewtherapeuticoptionguidedbyadaptiveactivationofimmuneresponsepathways |